tiprankstipranks
Trending News
More News >
Bath & Body Works (BBWI)
NYSE:BBWI
Advertisement

Bath & Body Works (BBWI) AI Stock Analysis

Compare
1,844 Followers

Top Page

BBWI

Bath & Body Works

(NYSE:BBWI)

Select Model
Select Model
Select Model
Neutral 63 (OpenAI - 4o)
Rating:63Neutral
Price Target:
$31.00
▲(20.48% Upside)
Bath & Body Works' overall stock score reflects strong earnings call performance and attractive valuation, offset by financial leverage concerns and weak technical indicators. The company's strategic initiatives and share repurchase plans are positive, but challenges in profitability and digital platform performance remain.
Positive Factors
Revenue Growth
Consistent revenue growth at the high end of guidance demonstrates strong market demand and effective sales strategies, supporting long-term business expansion.
Strategic Partnerships
The Disney partnership leverages popular IP to attract new customers and enhance brand appeal, potentially driving sustained revenue growth.
Cash Flow Generation
Strong cash flow growth indicates robust operational efficiency and financial health, providing the company with resources for investment and debt reduction.
Negative Factors
High Financial Leverage
High leverage and negative equity pose financial risks, limiting flexibility and increasing vulnerability to economic downturns, affecting long-term stability.
Digital Platform Underperformance
Underperformance in digital sales highlights challenges in adapting to e-commerce trends, potentially hindering growth in a digital-first retail environment.
Tariffs Impact on Profit
Tariff impacts on gross profit reduce margins, pressuring profitability and necessitating strategic cost management to maintain financial health.

Bath & Body Works (BBWI) vs. SPDR S&P 500 ETF (SPY)

Bath & Body Works Business Overview & Revenue Model

Company DescriptionBath & Body Works (BBWI) is a leading specialty retailer of personal care, fragrances, and home products, widely recognized for its high-quality offerings and innovative scents. Established in 1990, the company operates primarily in the retail sector, providing a diverse range of products including body lotions, shower gels, perfumes, candles, and home fragrance items. With a strong presence in both physical stores and online, Bath & Body Works aims to deliver a unique shopping experience characterized by their signature fragrances and seasonal collections.
How the Company Makes MoneyBath & Body Works generates revenue primarily through the sale of its personal care and home fragrance products. The company operates a multi-channel sales model, which includes brick-and-mortar retail stores, an e-commerce platform, and strategic partnerships with third-party retailers. Key revenue streams include direct sales from retail locations, online sales, and seasonal promotions that attract customers. Additionally, Bath & Body Works benefits from loyalty programs that encourage repeat purchases and increase customer retention. The brand also engages in frequent promotional events and offers limited-time collections, which drive foot traffic and boost sales. Collaborations with influencers and seasonal marketing campaigns further enhance brand visibility and contribute to revenue growth.

Bath & Body Works Earnings Call Summary

Earnings Call Date:Aug 28, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Nov 12, 2025
Earnings Call Sentiment Neutral
The earnings call detailed a quarter with strong revenue and earnings performance, led by successful sales events and strategic partnerships. While there were notable achievements in expanding the loyalty program and executing brand partnerships, challenges in digital platform performance and tariff impacts on gross profit were significant concerns. The company is taking steps to address these issues and is optimistic about long-term growth opportunities.
Q2-2025 Updates
Positive Updates
Strong Revenue and Earnings
Ended the quarter with revenue and adjusted earnings at the high end of guidance range. Raised the low end of the full-year adjusted earnings per share guidance.
Successful Semiannual Sale
Strong performance led by a focused execution during the semiannual sale, which was strategically shifted back by two weeks.
Disney Partnership
Announced a multiyear partnership with Disney, building on the successful momentum of Disney Princesses and Disney Villains collaborations.
Growth in Men's Business and Sanitizer Products
The men's business and sanitizer products, including moisturizing PocketBacs and 1-ounce sanitizer sprays, performed above expectations.
Loyalty Program Expansion
Active loyalty members increased by 5% compared to the prior year, reaching approximately 39 million.
Share Repurchase Program
Increased planned share repurchases for the year from $300 million to $400 million.
Negative Updates
Digital Platform Underperformance
Digital business declined, with direct net sales down 10% compared to last year.
Tariffs Impact on Gross Profit
Tariffs negatively impacted gross profit by approximately $85 million for the year, with a significant $40 million impact expected in Q3.
Challenges in Body Care Segment
Disappointed with the Body Care segment, which was down low single digits, with underperformance during Mother's Day.
SG&A Deleverage
Adjusted SG&A as a percentage of net sales increased by 110 basis points compared to the prior year due to selling expenses and higher healthcare costs.
Company Guidance
During Bath & Body Works' Second Quarter 2025 Earnings Conference Call, the company provided updated guidance, highlighting strong performance and strategic initiatives. They reported net sales growth of 1.5% and adjusted earnings per diluted share of $0.37, both at the high end of their projections. For the full year, Bath & Body Works revised their net sales growth guidance to between 1.5% and 2.7%, while increasing the low end of their adjusted earnings per share guidance to a range of $3.35 to $3.60. The company expects to mitigate an $85 million gross profit impact from tariffs through strategic sourcing and operational efficiencies. Bath & Body Works also plans to repurchase $400 million in shares, up from $300 million, reflecting confidence in their cash flow and business fundamentals. The company outlined three key initiatives for growth: enhancing their digital platform, emphasizing product efficacy, and expanding distribution channels, including partnerships with college bookstores to reach younger consumers.

Bath & Body Works Financial Statement Overview

Summary
Bath & Body Works shows strong revenue growth and cash flow generation, but profitability margins and high financial leverage pose significant challenges. The company needs to address its high debt levels and improve profitability for long-term stability.
Income Statement
65
Positive
Bath & Body Works shows a mixed performance in its income statement. The TTM data indicates a strong revenue growth rate of 31.3%, which is a positive sign of recovery and expansion. However, the gross profit margin and net profit margin have declined compared to previous years, indicating pressure on profitability. The EBIT and EBITDA margins remain stable, suggesting operational efficiency, but the declining net income is a concern.
Balance Sheet
40
Negative
The balance sheet reveals significant financial leverage, with a negative stockholders' equity leading to a high debt-to-equity ratio. This indicates potential financial risk and instability. The return on equity is negative, reflecting challenges in generating returns for shareholders. The equity ratio is also negative, highlighting the company's reliance on debt financing.
Cash Flow
70
Positive
Cash flow analysis shows positive trends, with a 25.6% growth in free cash flow in the TTM period, indicating improved cash generation. The operating cash flow to net income ratio is strong, suggesting good cash conversion. However, the free cash flow to net income ratio indicates some pressure on cash flow relative to profitability.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue7.37B7.31B7.43B7.56B7.88B6.43B
Gross Profit3.29B3.23B3.24B3.25B3.85B3.10B
EBITDA1.56B1.62B1.64B1.61B2.17B2.08B
Net Income728.00M798.00M878.00M800.00M1.33B844.00M
Balance Sheet
Total Assets4.81B4.87B5.46B5.49B6.03B11.57B
Cash, Cash Equivalents and Short-Term Investments364.00M674.00M1.08B1.23B1.98B3.57B
Total Debt4.99B4.96B5.57B6.05B6.01B7.48B
Total Liabilities6.36B6.25B7.09B7.70B7.54B12.23B
Stockholders Equity-1.55B-1.39B-1.63B-2.21B-1.52B-662.00M
Cash Flow
Free Cash Flow783.00M660.00M656.00M816.00M1.22B1.81B
Operating Cash Flow1.00B886.00M954.00M1.14B1.49B2.04B
Investing Cash Flow-217.00M-162.00M-286.00M-328.00M-259.00M-219.00M
Financing Cash Flow-934.00M-1.13B-815.00M-1.56B-3.19B610.00M

Bath & Body Works Technical Analysis

Technical Analysis Sentiment
Negative
Last Price25.73
Price Trends
50DMA
29.82
Negative
100DMA
29.71
Negative
200DMA
31.96
Negative
Market Momentum
MACD
-0.92
Positive
RSI
32.47
Neutral
STOCH
3.26
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BBWI, the sentiment is Negative. The current price of 25.73 is below the 20-day moving average (MA) of 29.09, below the 50-day MA of 29.82, and below the 200-day MA of 31.96, indicating a bearish trend. The MACD of -0.92 indicates Positive momentum. The RSI at 32.47 is Neutral, neither overbought nor oversold. The STOCH value of 3.26 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BBWI.

Bath & Body Works Risk Analysis

Bath & Body Works disclosed 41 risk factors in its most recent earnings report. Bath & Body Works reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Bath & Body Works Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
23.71B20.2746.14%2.94%4.57%
79
Outperform
9.31B9.9619.36%2.54%-5.24%-12.89%
77
Outperform
7.69B23.4825.38%2.46%10.93%-10.83%
70
Outperform
15.66B20.4028.65%5.09%-2.21%-37.30%
63
Neutral
$5.46B7.87-52.83%3.11%-0.18%-18.95%
59
Neutral
6.01B48.48-14.58%2.38%-38.88%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BBWI
Bath & Body Works
25.73
-3.43
-11.76%
BBY
Best Buy Co
74.52
-20.35
-21.45%
ULTA
Ulta Beauty
528.80
125.51
31.12%
VIPS
Vipshop
18.89
6.00
46.55%
ETSY
Etsy
60.62
6.55
12.11%
MNSO
MINISO Group Holding
25.03
8.89
55.08%

Bath & Body Works Corporate Events

Business Operations and StrategyFinancial Disclosures
Bath & Body Works Reports Q2 Financial Results
Positive
Aug 28, 2025

On August 28, 2025, Bath & Body Works reported its second quarter financial results, showing a 1.5% increase in net sales to $1.5 billion. The company adjusted its full-year earnings guidance, raising the low end of its adjusted earnings per share forecast. The company is focusing on strategic moves to enhance digital experiences, product efficacy, and distribution expansion, aiming for durable long-term growth. Despite a decrease in earnings per diluted share compared to the previous year, the company remains optimistic about its growth prospects.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 06, 2025